ID

34183

Description

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT01975376

Lien

https://clinicaltrials.gov/show/NCT01975376

Mots-clés

  1. 15/01/2019 15/01/2019 -
Détendeur de droits

see on clinicaltrials.gov

Téléchargé le

15 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Cardiovascular Disease NCT01975376

Eligibility Cardiovascular Disease NCT01975376

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must be on background lipid lowering treatment.
Description

ID.1

Type de données

boolean

must be at high risk of a cv event.
Description

ID.2

Type de données

boolean

must have an ldl c >/=70 mg/dl (1.8 mmol/l) and < 100 mg/dl (2.6 mmol/l) or non-hdl-c >/= 100 mg/dl (2.6 mmol/l) and < 130 mg/dl (3.4 mmol/l).
Description

ID.3

Type de données

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
an ldl c < 70 mg/dl (1.8 mmol/l) or >/= 100 mg/dl (2.6 mmol/l) or non hdl-c < 100 mg/dl (2.6 mmol/l) or >/=130 mg/dl (3.4 mmol/l).
Description

ID.4

Type de données

boolean

planned coronary (pci or cabg) or other arterial revascularization.
Description

ID.5

Type de données

boolean

new york heart association class iv congestive heart failure or left ventricular ejection fraction < 25% by cardiac imaging.
Description

ID.6

Type de données

boolean

chronic renal insufficiency with creatinine clearance of <30 ml/min/1.73m^2 by mdrd formula or with end state renal disease on dialysis.
Description

ID.7

Type de données

boolean

history of hemorrhagic stroke.
Description

ID.8

Type de données

boolean

prior exposure to bococizumab or other investigational pcsk9 inhibitor.
Description

ID.9

Type de données

boolean

Similar models

Eligibility Cardiovascular Disease NCT01975376

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
must be on background lipid lowering treatment.
boolean
ID.2
Item
must be at high risk of a cv event.
boolean
ID.3
Item
must have an ldl c >/=70 mg/dl (1.8 mmol/l) and < 100 mg/dl (2.6 mmol/l) or non-hdl-c >/= 100 mg/dl (2.6 mmol/l) and < 130 mg/dl (3.4 mmol/l).
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
an ldl c < 70 mg/dl (1.8 mmol/l) or >/= 100 mg/dl (2.6 mmol/l) or non hdl-c < 100 mg/dl (2.6 mmol/l) or >/=130 mg/dl (3.4 mmol/l).
boolean
ID.5
Item
planned coronary (pci or cabg) or other arterial revascularization.
boolean
ID.6
Item
new york heart association class iv congestive heart failure or left ventricular ejection fraction < 25% by cardiac imaging.
boolean
ID.7
Item
chronic renal insufficiency with creatinine clearance of <30 ml/min/1.73m^2 by mdrd formula or with end state renal disease on dialysis.
boolean
ID.8
Item
history of hemorrhagic stroke.
boolean
ID.9
Item
prior exposure to bococizumab or other investigational pcsk9 inhibitor.
boolean

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial